Executive Director, Head of Hematology ResearchBioMarin PharmaceuticalNovato, California, United States
OC 02.1 - Kinetic profiles of anti-AAV5 antibody generation and clearance in neonatal, infant, and adult hemophilia A dogs
Saturday, June 22, 202413:00 – 13:15 ICT
PB0221 - Persistent and stable therapeutic levels of transgenic FVIII expression following AAV delivery to adult and infant hemophilic dogs
Sunday, June 23, 202413:45 – 14:45 ICT
